ALAN C. SMITH, Securities Offerings, Mergers and Acquisitions, Venture Capital Financings & Strategic Investments, Corporate Governance : Fenwick & West LLP

ALAN C. SMITH

Emphasis

		Securities Offerings
		Mergers and Acquisitions
		Venture Capital Financings & Strategic Investments
		Corporate Governance

Profile

Mr. Smith is resident in the Seattle office. His practice focuses on representing emerging and public companies in mergers and acquisitions, capital markets offerings and venture capital and strategic investments.

In addition, Mr. Smith has represented many of the region's leading public companies, for which he has advised on corporate governance and securities matters and has led a variety of private and public financing transactions and mergers and acquisitions. He also has an active venture capital financing practice, having represented many West Coast venture capital firms.

Prior to joining Fenwick & West, he was a partner at Orrick, Herrington & Sutcliffe LLP and the chair of Orrick’s Seattle office.

Education

Stanford Law School, J.D., Order of the Coif, 1996

Stanford University, B.A., 1993

Admitted to Practice

Mr. Smith is admitted to practice in Oregon and Washington and before the United States Courts of Appeals for the 9th Circuit.

Additional Information

Mr. Smith has been recognized as one of the top corporate and mergers and acquisitions lawyers in Washington by Chambers USA, as a Super Lawyer by Washington Law & Politics from 2003 through 2008 and as one of the "Top 40 Under 40" by the Puget Sound Business Journal in 2004.

He is a frequent speaker on corporate finance topics, including the initial public offering process, venture and angel financing and mergers and acquisitions.

He was a law clerk to Judge Stephen S. Trott of the U.S. Ninth Circuit Court of Appeals in 1996-1997.

He has considerable experience advising technology, life sciences, Internet, and other high growth companies. His clients have included:

Representative Clients

		Cardiac Dimensions, Inc.
		Corixa Corporation
		Corus Pharma, Inc.
		ICOS Corporation
		Immunex Corp.
		Infinia Corporation
		NeuroVista Corporation
		Onyx Software Corp
		Redfin
		Smartsheet.com Inc
		SonoSite, Inc.
		Symetra Financial Corporation
		Theraclone Sciences, Inc.
		Trubion Pharmaceuticals Inc.
		Xeround, Inc.

ALAN C. SMITH

Partner,
Corporate Group

P: 206.389.4530
F: 206.389.4511

acsmith@fenwick.com

		Printable profile
		Email profile
		vCard Contact

The contents of this Web page are not intended, and cannot be considered, as legal advice or opinion.
©2003-2010 Fenwick & West LLP · Silicon Valley · San Francisco · Seattle · Boise · All rights reserved.